Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation in cancer patients.
M. Mori
No relevant relationships to disclose
T. Ashikaga
No relevant relationships to disclose
S. M. Grunberg
No relevant relationships to disclose